Avantra Family Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
10,067
-575
-5% -$46.4K 0.5% 57
2026
Q1
$922K Buy
10,642
+187
+2% +$17.9K 0.69% 44
2025
Q4
$1M Buy
10,455
+226
+2% +$22K 0.73% 43
2025
Q3
$974K Buy
10,229
+1,149
+13% +$106K 0.73% 40
2025
Q2
$792K Sell
9,080
-1,803
-17% -$153K 0.65% 43
2025
Q1
$978K Buy
10,883
+682
+7% +$61K 0.94% 32
2024
Q4
$815K Buy
+10,201
New +$883K 0.76% 39

Other funds holding MDT

Avantra Family Wealth's MDT Position: Q2 2026 in Review

Avantra Family Wealth reduced its Medtronic (MDT) stake by 5.4% in Q2 2026, selling an estimated $46.4K and leaving 10,067 shares worth $788K. The position accounts for 0.5% of the portfolio, ranked #57.

Avantra Family Wealth first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1M in Q4 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Avantra Family Wealth held 10,067 shares of Medtronic worth $788K as of Q2 2026.
  • Avantra Family Wealth sold 575 Medtronic shares in Q2 2026, an estimated $46.4K.
  • Medtronic made up 0.5% of Avantra Family Wealth's portfolio in Q2 2026, its #57 holding.
  • Avantra Family Wealth first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Avantra Family Wealth's Medtronic position peaked at $1M in Q4 2025.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Avantra Family Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.